UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.

Mutations At The FLT3 Activation Loop D835 Residue Confer Differential Resistance To Clinically Active FLT3 Inhibitors.

Blood

Kimberly Lin, Catherine C Smith, Sara Salerno, Neil P. Shah. Mutations At The FLT3 Activation Loop D835 Residue Confer Differential Resistance To Clinically Active FLT3 Inhibitors. Blood. 2013 Nov 15; 122(21):3929-3929.

2013

https://researcherprofiles.org/profile/231933182

Kimberly Lin, Catherine C Smith, Sara Salerno, Neil P. Shah

Search form

You are here

Mutations At The FLT3 Activation Loop D835 Residue Confer Differential Resistance To Clinically Active FLT3 Inhibitors.